BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 34434981)

  • 1. Immune Checkpoint Inhibitors Mediated Lymphocytic and Giant Cell Myocarditis: Uncovering Etiological Mechanisms.
    Rikhi R; Karnuta J; Hussain M; Collier P; Funchain P; Tang WHW; Chan TA; Moudgil R
    Front Cardiovasc Med; 2021; 8():721333. PubMed ID: 34434981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Pathogenic Immune Cell Subsets Associated With Checkpoint Inhibitor-Induced Myocarditis.
    Zhu H; Galdos FX; Lee D; Waliany S; Huang YV; Ryan J; Dang K; Neal JW; Wakelee HA; Reddy SA; Srinivas S; Lin LL; Witteles RM; Maecker HT; Davis MM; Nguyen PK; Wu SM
    Circulation; 2022 Jul; 146(4):316-335. PubMed ID: 35762356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Checkpoint Inhibitors-Associated Myocarditis: Diagnosis, Treatment and Current Status on Rechallenge.
    Frascaro F; Bianchi N; Sanguettoli F; Marchini F; Meossi S; Zanarelli L; Tonet E; Serenelli M; Guardigli G; Campo G; Calabrò L; Pavasini R
    J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-Checkpoint Inhibitor-Related Myocarditis: Where We Are and Where We Will Go.
    Vergara A; De Felice M; Cesaro A; Gragnano F; Pariggiano I; Golia E; De Pasquale A; Blasi E; Fimiani F; Monda E; Limongelli G; Calabrò P
    Angiology; 2023 Sep; ():33197231201929. PubMed ID: 37699402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of low-intensity pulsed ultrasound on immune checkpoint inhibitor-related myocarditis via fine-tuning CD4
    Fu S; Guo Z; Xu X; Li Y; Choi S; Zhao P; Shen W; Gao F; Wang C; Chen S; Li Y; Tian J; Sun P
    Cancer Immunol Immunother; 2024 Jan; 73(1):15. PubMed ID: 38236243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediators and mechanisms of immune checkpoint inhibitor-associated myocarditis: Insights from mouse and human.
    Gong J; Neilan TG; Zlotoff DA
    Immunol Rev; 2023 Sep; 318(1):70-80. PubMed ID: 37449556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Checkpoint Inhibitor-Associated Myocarditis: A Literature Review.
    Gul R; Shehryar M; Mahboob A; Kareem HK; Inayat A; Safi D; Kamran A
    Cureus; 2024 Jan; 16(1):e52952. PubMed ID: 38406102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective screening for myocarditis in cancer patients treated with immune checkpoint inhibitors.
    Furukawa A; Tamura Y; Taniguchi H; Kawamura A; Nagase S; Hayashi A; Tada Y; Sase K; Hatake K
    J Cardiol; 2023 Jan; 81(1):63-67. PubMed ID: 35953399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune checkpoint inhibitor myocarditis: elucidating the spectrum of disease through endomyocardial biopsy.
    Palaskas NL; Segura A; Lelenwa L; Siddiqui BA; Subudhi SK; Lopez-Mattei J; Durand JB; Deswal A; Zhao B; Maximilian Buja L; Iliescu C
    Eur J Heart Fail; 2021 Oct; 23(10):1725-1735. PubMed ID: 34114291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of Disease Specific Cardiac Macrophages in Immune Checkpoint Inhibitor Myocarditis.
    Ma P; Liu J; Qin J; Lai L; Heo GS; Luehmann H; Sultan D; Bredemeyer A; Bajapa G; Feng G; Jimenez J; Parks A; Amrute J; Villanueva A; Liu Y; Lin CY; Mack M; Amancherla K; Moslehi J; Lavine KJ
    bioRxiv; 2023 Apr; ():. PubMed ID: 37162929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Checkpoint Inhibitor-Related Myocarditis: Recognition, Surveillance, and Management.
    Kuhnly NM; Coviello J
    Clin J Oncol Nurs; 2022 Feb; 26(1):54-60. PubMed ID: 35073300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune checkpoint inhibitor-associated myocarditis : Case reports and a review of the literature.
    Osinga TE; Oosting SF; van der Meer P; de Boer RA; Kuenen BC; Rutgers A; Bergmann L; Oude Munnink TH; Jalving M; van Kruchten M
    Neth Heart J; 2022 Jun; 30(6):295-301. PubMed ID: 35061242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central memory CD4+ T cells play a protective role against immune checkpoint inhibitor-associated myocarditis.
    Yu J; Long B; Li Z; Tian X; Li D; Long J; Wang YJ; Chen Y; Zhang F; Liu H; Qian C; Shan J
    Cardiovasc Res; 2024 Jun; ():. PubMed ID: 38850163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis.
    Cautela J; Zeriouh S; Gaubert M; Bonello L; Laine M; Peyrol M; Paganelli F; Lalevee N; Barlesi F; Thuny F
    J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33298621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the Literature.
    Agrawal N; Khunger A; Vachhani P; Colvin TA; Hattoum A; Spangenthal E; Curtis AB; Dy GK; Ernstoff MS; Puzanov I
    Case Rep Oncol; 2019; 12(1):260-276. PubMed ID: 31011325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cells specific for α-myosin drive immunotherapy-related myocarditis.
    Axelrod ML; Meijers WC; Screever EM; Qin J; Carroll MG; Sun X; Tannous E; Zhang Y; Sugiura A; Taylor BC; Hanna A; Zhang S; Amancherla K; Tai W; Wright JJ; Wei SC; Opalenik SR; Toren AL; Rathmell JC; Ferrell PB; Phillips EJ; Mallal S; Johnson DB; Allison JP; Moslehi JJ; Balko JM
    Nature; 2022 Nov; 611(7937):818-826. PubMed ID: 36385524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Checkpoint Inhibitor-Related Myositis Overlapping With Myocarditis: An Institutional Case Series and a Systematic Review of Literature.
    Nakagomi Y; Tajiri K; Shimada S; Li S; Inoue K; Murakata Y; Murata M; Sakai S; Sato K; Ieda M
    Front Pharmacol; 2022; 13():884776. PubMed ID: 35645839
    [No Abstract]   [Full Text] [Related]  

  • 18. The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment : Including myocarditis and the new entity of non inflammatory left ventricular dysfunction.
    Andres MS; Ramalingam S; Rosen SD; Baksi J; Khattar R; Kirichenko Y; Young K; Yousaf N; Okines A; Huddart R; Harrington K; Furness AJS; Turajlic S; Pickering L; Popat S; Larkin J; Lyon AR
    Cardiooncology; 2022 Nov; 8(1):21. PubMed ID: 36424659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart-Specific Immune Responses in an Animal Model of Autoimmune-Related Myocarditis Mitigated by an Immunoproteasome Inhibitor and Genetic Ablation.
    Bockstahler M; Fischer A; Goetzke CC; Neumaier HL; Sauter M; Kespohl M; Müller AM; Meckes C; Salbach C; Schenk M; Heuser A; Landmesser U; Weiner J; Meder B; Lehmann L; Kratzer A; Klingel K; Katus HA; Kaya Z; Beling A
    Circulation; 2020 Jun; 141(23):1885-1902. PubMed ID: 32160764
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Boughdad S; Latifyan S; Fenwick C; Bouchaab H; Suffiotti M; Moslehi JJ; Salem JE; Schaefer N; Nicod-Lalonde M; Costes J; Perreau M; Michielin O; Peters S; Prior JO; Obeid M
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34686542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.